Emergence and Global Dissemination of Host-Specific Streptococcus agalactiae Clones

ABSTRACT To examine the global diversity of Streptococcus agalactiae (group B streptococci [GBS]) and to elucidate the evolutionary processes that determine its population genetics structure and the reported changes in host tropism and infection epidemiology, we examined a collection of 238 bovine and human isolates from nine countries on five continents. Phylogenetic analysis based on the sequences of 15 housekeeping genes combined with patterns of virulence-associated traits identified a genetically heterogeneous core population from which virulent lineages occasionally emerge as a result of recombination affecting major segments of the genome. Such lineages, like clonal complex 17 (CC17) and two distinct clusters of CC23, are exclusively adapted to either humans or cattle and successfully spread globally. The recent emergence and expansion of the human-associated and highly virulent sequence type 17 (ST17) could conceivably account, in part, for the increased prevalence of neonatal GBS infections after 1960. The composite structure of the S. agalactiae genome invalidates phylogenetic inferences exclusively based on multilocus sequence typing (MLST) data and thereby the previously reported conclusion that the human-associated CC17 emerged from the bovine-associated CC67. IMPORTANCE Group B streptococci (GBS) (Streptococcus agalactiae) have long been recognized as important causes of mastitis in cattle. After 1960, GBS also became the most prevalent cause of invasive and often fatal infections in newborns. At the same time, GBS are carried by a substantial proportion of healthy individuals. The aims of this study were to elucidate the genetic mechanisms that lead to diversification of the GBS population and to examine the relationship between virulence and host preference of evolutionary lineages of GBS. Genetic analysis of GBS isolates from worldwide sources demonstrated epidemic clones adapted specifically to either the human or bovine host. Such clones seem to emerge from a genetically heterogeneous core population as a result of recombination affecting major segments of the genome. Emergence and global spread of certain clones explain, in part, the change in epidemiology of GBS disease and may have implications for prevention. Group B streptococci (GBS) (Streptococcus agalactiae) have long been recognized as important causes of mastitis in cattle. After 1960, GBS also became the most prevalent cause of invasive and often fatal infections in newborns. At the same time, GBS are carried by a substantial proportion of healthy individuals. The aims of this study were to elucidate the genetic mechanisms that lead to diversification of the GBS population and to examine the relationship between virulence and host preference of evolutionary lineages of GBS. Genetic analysis of GBS isolates from worldwide sources demonstrated epidemic clones adapted specifically to either the human or bovine host. Such clones seem to emerge from a genetically heterogeneous core population as a result of recombination affecting major segments of the genome. Emergence and global spread of certain clones explain, in part, the change in epidemiology of GBS disease and may have implications for prevention.

[1]  Simone Aymanns,et al.  Human Serum Induces Streptococcal C5a Peptidase Expression , 2009, Infection and Immunity.

[2]  I. Margarit,et al.  Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. , 2009, The Journal of infectious diseases.

[3]  P. Glaser,et al.  Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae , 2008, Proceedings of the National Academy of Sciences.

[4]  F. Kong,et al.  Use of Phenotypic and Molecular Serotype Identification Methods To Characterize Previously Nonserotypeable Group B Streptococci , 2008, Journal of Clinical Microbiology.

[5]  D. Dunn,et al.  Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999 , 2008, Journal of Clinical Microbiology.

[6]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[7]  R. Rappuoli,et al.  Group B Streptococcus: global incidence and vaccine development , 2006, Nature Reviews Microbiology.

[8]  J. R. Hull,et al.  High-Affinity Interaction between Fibronectin and the Group B Streptococcal C5a Peptidase Is Unaffected by a Naturally Occurring Four-Amino-Acid Deletion That Eliminates Peptidase Activity , 2006, Infection and Immunity.

[9]  I. Margarit,et al.  Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae , 2006, Molecular microbiology.

[10]  C. Buchrieser,et al.  Genomic diversity and evolution within the species Streptococcus agalactiae. , 2006, Microbes and infection.

[11]  B. Spratt,et al.  Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Troendle,et al.  Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study , 2006, Journal of Clinical Microbiology.

[13]  D. Huson,et al.  Application of phylogenetic networks in evolutionary studies. , 2006, Molecular biology and evolution.

[14]  Jaideep P. Sundaram,et al.  Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Bruant,et al.  Acquisition of Insertion Sequences and the GBSi1 Intron by Streptococcus agalactiae Isolates Correlates with the Evolution of the Species , 2005, Journal of bacteriology.

[16]  B. Spratt,et al.  Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching , 2005, Journal of Clinical Microbiology.

[17]  R. Rappuoli,et al.  Genome Analysis Reveals Pili in Group B Streptococcus , 2005, Science.

[18]  Gustavo Glusman,et al.  Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides , 2005, Infection and Immunity.

[19]  M. Wiedmann,et al.  Molecular Subtyping and Characterization of Bovine and Human Streptococcus agalactiae Isolates , 2005, Journal of Clinical Microbiology.

[20]  G. Lindahl,et al.  Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.

[21]  M. Gottschalk,et al.  Serotype III Streptococcus agalactiae from Bovine Milk and Human Neonatal Infections1 , 2004, Emerging infectious diseases.

[22]  T. Peto,et al.  Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor , 2004, Journal of Clinical Microbiology.

[23]  H. Davies,et al.  Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. , 2004, The Journal of infectious diseases.

[24]  A. Adriaanse,et al.  Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe , 2004, The Pediatric infectious disease journal.

[25]  N. Uldbjerg,et al.  Dynamics of Streptococcus agalactiae Colonization in Women during and after Pregnancy and in Their Infants , 2004, Journal of Clinical Microbiology.

[26]  C. Lämmler,et al.  Determination of epidemiological relationships of Streptococcus agalactiae isolated from bovine mastitis. , 2003, FEMS microbiology letters.

[27]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[28]  W. Melchers,et al.  Genetic analysis of Streptococcus agalactiae strains isolated from neonates and their mothers. , 2003, FEMS immunology and medical microbiology.

[29]  M. Stronati,et al.  [Streptococcus agalactiae]. , 2003, La Pediatria medica e chirurgica : Medical and surgical pediatrics.

[30]  Carmen Buchrieser,et al.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.

[31]  Ian T. Paulsen,et al.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Lindahl,et al.  Streptococcal β Protein Has Separate Binding Sites for Human Factor H and IgA-Fc* , 2002, The Journal of Biological Chemistry.

[33]  F. Kong,et al.  Serotype Identification of Group B Streptococci by PCR and Sequencing , 2002, Journal of Clinical Microbiology.

[34]  B. Spellerberg,et al.  Horizontal gene transfer and host specificity of beta‐haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb , 2001, Molecular microbiology.

[35]  F. Michel,et al.  Mutually Exclusive Distribution of IS1548 and GBSi1, an Active Group II Intron Identified in Human Isolates of Group B Streptococci , 2001, Journal of bacteriology.

[36]  E. Feil,et al.  Population structure and evolutionary dynamics of pathogenic bacteria , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  J. Hedegaard,et al.  Investigation of the translation-initiation factor IF2 gene, infB, as a tool to study the population structure of Streptococcus agalactiae. , 2000, Microbiology.

[38]  J. Harel,et al.  Characterization of Streptococcus agalactiae Isolates of Bovine and Human Origin by Randomly Amplified Polymorphic DNA Analysis , 2000, Journal of Clinical Microbiology.

[39]  D. Haburchak,et al.  Topley and Wilson's Microbiology and Microbial Infections , 1999 .

[40]  A. Schuchat Group B streptococcus , 1999, The Lancet.

[41]  A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[42]  M. Sellin,et al.  Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. , 1998, The Journal of infectious diseases.

[43]  P. Berche,et al.  Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalactiae. , 1997, Gene.

[44]  G. Keefe,et al.  Streptococcus agalactiae mastitis: a review. , 1997, The Canadian veterinary journal = La revue veterinaire canadienne.

[45]  N. E. Jensen,et al.  Epidemiological aspects of group B streptococci of bovine and human origin , 1996, Epidemiology and Infection.

[46]  P. Ferrieri,et al.  Conservation of the C5a peptidase genes in group A and B streptococci , 1996, Infection and immunity.

[47]  M. Kilian,et al.  Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease , 1996, Infection and immunity.

[48]  A. Podbielski,et al.  Similarity between the group B and A streptococcal C5a peptidase genes , 1992, Infection and immunity.

[49]  P. G. Jerlström,et al.  The IgA‐binding β antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions , 1991, Molecular microbiology.

[50]  K. Timmis,et al.  The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. , 1991, Molecular microbiology.

[51]  J. Elliott,et al.  Whole-cell protein patterns of nonhemolytic group B, type Ib, streptococci isolated from humans, mice, cattle, frogs, and fish , 1990, Journal of clinical microbiology.

[52]  M. T. Parker,et al.  Streptococcus and Lactobacillus. , 1990 .

[53]  J. Musser,et al.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Ross Occasional Review: Group-B Streptococcus—Profile of an Organism* , 1984 .

[55]  P. Ross Group-B streptococcus--profile of an organism. , 1984, Journal of medical microbiology.

[56]  D. Okada,et al.  The emergence of group B streptococci in infections of the newborn infant. , 1977, Annual review of medicine.

[57]  R. F. Smith,et al.  Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. , 1968, Applied microbiology.